• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Alport Syndrome

Alport Syndrome - 15 Studies Found

Completed : European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
:
  • Alport Syndrome
  • Hereditary Kidney Disease
  • Drug: ACE-inhibitor observatio

Completed : Biomarker for Patient With Alport Disease or Highly Suspected for Alport Disease
:
  • Nephritis, Hereditary
  • Alport Syndrome
  • Drug: Ramipril Ramipril (Delix

Completed : Enalapril in Collagen Type 4 Nephropathy
: Collagen Type-4 Nephropathies
: 2011-10-27
COMPLETED : A Study to Evaluate Setanaxib in Patients With Alport Syndrome
: Alport Syndrome
: 2025-09-03
: Setanaxib (formerly GKT137831) is a first-in-class inhibitor of the human protein NADPH NOX1/4.It is a low molecular weight organic molecul
<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.